Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres
Crossref DOI link: https://doi.org/10.1186/s40169-017-0172-3
Published Online: 2017-11-03
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toellner, Hannah http://orcid.org/0000-0001-6316-4617
Hughes, G.
Beswick, W.
Crooks, M. G.
Donaldson, C.
Forrest, I.
Hart, S. P.
Leonard, C.
Major, M.
Simpson, A. J.
Chaudhuri, N.
Version of Record valid from 2017-11-03
License valid from 2017-11-03